|Name of Journal||Artificial Intelligence in Gastroenterology|
|Title Abbreviation||Artif Intell Gastroenterol|
Artificial Intelligence in Gastroenterology (AIG, Artif Intell Gastroenterol) is a high-quality, online, open-access, single-blind peer-reviewed journal that is published by the Baishideng Publishing Group. Accepting both solicited and unsolicited manuscripts, the AIG mainly publishes high quality clinical research articles to promote the application of artificial intelligence in gastrointestinal cancer, liver cancer, pancreatic cancer, hepatitis B, hepatitis C, nonalcoholic fatty liver disease, inflammatory bowel disease, irritable bowel syndrome, and Helicobacter pylori infection research with the ultimate objective of improving early screening, diagnosis, and treatment of these diseases. The types of articles published in the AIG include Editorial, Opinion Review, Frontier, Review, Minireview, Topic Highlight, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Advances in Diagnosis, Advances in Treatment, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.
The primary aim of the AIG is to provide scholars and readers from various fields of gastroenterology and hepatology research with a platform to publish high quality clinical research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of manuscript publication, the AIG has implemented a variety of measures.
First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report.
Second, articles published in the AIG must undergo rigorous cross-international peer review, where peer reviewers and authors come from different countries and independent peer reviewers are chosen by the editorial office, not by authors, to ensure the fairness of peer review.
Third, designation of co-first authors or co-corresponding authors is not permitted.
Fourth, the AIG accepts a manuscript based mainly on its novelty, innovativeness, data accuracy, picture reliability, clear language expression, and ethical requirements. Of note, peer reviewers will complete the peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript.
Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production and release, must be completed within 7 days.
Finally, the peer review report, author’s
response to the peer review report, biostatistics review certificate, copyright
license agreement, institutional ethics committee approval document, informed
consent, conflict-of-interest statement, CrossCheck detection report, authors’
personal ORCID numbers, funding information, language editing certificate, and
other relevant documents will be published online along with the article to
ensure that the publishing process is open and transparent.
The AIG mainly publishes clinical
gastroenterology, hepatology, gastrointestinal surgery, and gastrointestinal
endoscopy research results obtained using artificial intelligence technology,
including those from the clinical research of gastrointestinal diseases as well
as their genetic testing, histopathological diagnosis, cytological diagnosis,
imaging diagnosis, ultrasonic diagnosis, epidemiology, clinical diagnosis,
individualized treatment, radiotherapy, chemotherapy, and biological treatment.
|Open Access||Open access|
There is currently no indexing.
|Journal Metrics||There is currently no impact factor.|
|Article Processing Charge||Article processing charge|
|Article Reprints||Article reprints|
|Help Desk||Help desk|
|Special Statement||Special statement|
|Copyright ©||© 2004-2019 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA|
|Contact Us||Contact us|